Bio-Solutions Corp. Appoints Dr.Gilles Chaumillon, PhD, MBA as its Chief Executive Officer

Bio-Solutions Corp. (OTCBB:BISU), a biotechnology company specializing in veterinary care and organic dietary supplements for livestock, is now ready to go ahead into the second phase of its growth strategy. The arrival of Dr.Gilles Chaumillon, PhD/MBA, as Chief Executive Officer and President, will enable the company to achieve its principal corporate objective and to position itself as a key solution provider in the field.

Dr. Chaumillon has vast managerial experience within the industry of life sciences, primarily with organic products. Notably, he has occupied the functions of director at Aeterna Zantaris (AEZ), Biosyntech (BSY), as well as companies in the private sector of the same field. He possesses a PhD in Marine Biology from Universite Laval (1997) and an MBA in Biotechnology Management from Universite du Quebec a Montreal (2003).

Bio-Solutions Corp has all the attributes to quickly make its mark, within the innovative markets in the field of veterinary care and organic dietary supplements. Second generation organic products can now offer additional efficiency compared to current products on the market, as well as having a better safety profile. This is a significant trend for the industry.

Bio-Solutions will develop its product line by the acquisition of new technologies or by the signing licensing agreements. "Our international networks of collaborators will enable us to expand our product line in order to have a diversified product portfolio. Consequently, this will allow us to generate revenue for the company rapidly and to distinguish ourselves from the other enterprises active in the field", said Dr.Gilles Chaumillon, President of Bio-Solutions Corp. "For example purposes, the global market for veterinary products represents 19 billion dollars and the overall market for organic products represents over 700 million dollars in North America. It is important to point out that in the market of organic products, Bio-solutions Corp. will be attentive to all opportunities offered by high potential and innovative products" further added Dr.Chaumillon.

For more information on Bio-Solutions Corp. and its products, please visit the company's website at www.bio-solutionscorp.com

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause Bio-Solution Corp's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of the Company to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements, and we disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments except if we are requested to do so by a governmental authority or applicable law.

SOURCE: Bio-Solutions Corp.

Investor & Public Relations
ONZ Communications
Salem Tewolde
514-567-0282
salem@onzcom.com

Related terms: biology, biotechnology, business, ceo, clinical, corporate, law, livestock, marine, market, montreal, north america, president, products, quebec, revenue, securities, veterinary